GM invests in single-step cellulosic ethanol pioneer Mascoma

In New Hampshire, General Motors and Mascoma announced a strategic relationship to develop cellulosic ethanol, which included an undisclosed equity investment in Mascoma by GM. Mascoma’s single-step biochemical process has received support from a host of high-profile investors and partners including the Department of Energy, Khosla Ventures and Kleiner, Perkins.

The investment by GM is the second in cellulosic ethanol, following its partnership with Coskata earlier this year. “Taken together, these technologies represent what we see as the best in the cellulosic ethanol future and cover the spectrum in science and commercialization,” GM President Fritz Henderson said. “Demonstrating the viability of sustainable non-grain based ethanol is critical to developing the infrastructure to support the flex-fuel vehicle market.”

Mascoma last month raised an additional $30 million in equity and $20 million in debt from Khosla Ventures, Atlas Venture, Flagship Ventures, Kleiner Perkins, Pinnacle Ventures, and VantagePoint Venture Partners. A Dartmouth College spin-off, Mascoma has commenced construction of its demonstration-scale plants, and is raising money to complete construction and fund future commercial-scale plants.

The company previously raised $40 million in venture funding and has received grants from three states related to its research. Dartmouth professors Lee Lynd and Charles Wyman founded Mascoma in 2005.

Mascoma decided late last year to move the location of its proposed cellulosic ethanol plant from Greece to Rome (NY), citing the need to be closer to biomass sources and the suitability of the former Griffiss Air Force Base as a facility. The switch had been mooted for some time and in September Mascoma appeared before the Oneida County Board in support of its plans to open in Rome.

The proposed demonstration plant would produce 500,000 gallons per year of cellulosic ethanol, and will commence production by March. The plant has received $14.8 million in assistance from New York state.

Last November, Mascoma acquired Celsys BioFuels, a cellulosic ethanol production technology company founded by a Purdue University team last year. The founder of Celsys has become the CTO of Mascoma.

Free Subscription to the Daily Biofuels Digest e-newsletter

Related Stories

Michigan State researchers develop one-step procedure for cellulosic ethanol enzymes; growing them inside the crop, instead of in bioreactors

In Michigan, researchers at Michigan State have developed a process to insert enzymes used to break down cellulose, into crops such as corn. The process, which is just beginning a testing phase, would...

SunEthanol receives $100,000 DOE grant for single-step cellulosic ethanol R&D

In Massachusetts, the US Department of Energy awarded $100,000 to SunEthanol to further develop its patented C3 process, which combines hydrolysis and fermentation into a single step. The five-step pr...

Marathon Oil invests $10 million in Mascoma

In Massachusetts, Mascoma received another $10 million in financing with an equity investment by Marathon Oil. The company said that it had received a total of $61 million in its latest funding drive,...

Mascoma announces layoffs, including company president, as cellulosic ethanol finance conditions deteriorate

In Massachusetts, cellulosic ethanol pioneer Mascoma announced that it had laid off up to 10 employees, including the company's president, Colin South. South, a New Zealander, was a co-founder of t...

German researchers identify new enzyme to convert xylose to ethanol in a single step; eliminates costly two-step process for cellulosic ethanol

In Germany, researchers at Goethe-University Frankfurt have developed a new process to convert xylose to ethanol by genetically modifying yeasts that previously would only convert glucose. The researc...

Mascoma adds two MIT luminaries to science advisory team, deeping cellulosic ethanol resources

In Massachusetts, Mascoma has expanded its Scientific Advisory Board with two appointments from MIT faculty. Dr. Chris Kaiser is head of the Biology Department at MIT, and manages a lab studying prote...